Your browser doesn't support javascript.
loading
Impact of CD33 and ABCB1 single nucleotide polymorphisms in patients with acute myeloid leukemia and advanced myeloid malignancies treated with decitabine plus gemtuzumab ozogamicin.
Short, Nicholas J; Richard-Carpentier, Guillaume; Kanagal-Shamanna, Rashmi; Patel, Keyur P; Konopleva, Marina; Papageorgiou, Ioannis; Pemmaraju, Naveen; Borthakur, Gautam; Ravandi, Farhad; DiNardo, Courtney D; Kadia, Tapan M; Kantarjian, Hagop; Lamba, Jatinder K; Daver, Naval.
Afiliación
  • Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Richard-Carpentier G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Papageorgiou I; Department of Pharmacotherapy & Translational Research, The University of Florida, Gainesville, Florida, USA.
  • Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lamba JK; Department of Pharmacotherapy & Translational Research, The University of Florida, Gainesville, Florida, USA.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Am J Hematol ; 95(9): E225-E228, 2020 09.
Article en En | MEDLINE | ID: mdl-32356320
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Hematológicas / Polimorfismo de Nucleótido Simple / Lectina 3 Similar a Ig de Unión al Ácido Siálico / Proteínas de Neoplasias Límite: Adult / Female / Humans / Male Idioma: En Revista: Am J Hematol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Hematológicas / Polimorfismo de Nucleótido Simple / Lectina 3 Similar a Ig de Unión al Ácido Siálico / Proteínas de Neoplasias Límite: Adult / Female / Humans / Male Idioma: En Revista: Am J Hematol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos